#relapses — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #relapses, aggregated by home.social.
-
https://www.europesays.com/ch/53754/ Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD #68% #become #by #demonstrating #ENSPRYNG #first #for #MOGAD #of #potential #reduces #relapses #Risk #Roche #Roche’s #satralizumab #to #treatment